How study design influences conclusions - Turm... - CLL Support
How study design influences conclusions - Turmeric miracle revisited
You need to be a member of this community to see this post.
Read more about...
10 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lym
Background: Current therapies for CLL/SLL have frequent toxicities, are non-curative, and several...
Update for UK FLAIR Study Participants who have come to the end of 6 years of Ibrutininb treatment.
Many patients were fortunate to receive Ibrutinib as their first treatment in the UK FLAIR study...
Rituximab hailed as a breakthrough for millions with Chronic Fatigue
A couple of days ago Sue (wroxham) mentioned yuppie flu in response to Ducksoup's post 'Fatigue,...
Does Untreated Asymptomatic CLL Carry Risks? …early treatment does not yet improve survival of certain patients, from 2 year study results.
Does Untreated Asymptomatic CLL Carry Risks? from Patient Empowerment Network on Vimeo....
Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus Venetoclax
ASH 2022: Dr. John Allan on Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with...
Related Posts
- YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
- An exercise pill would be prescribed to every cancer patient worldwide and viewed as a major breakthrough in cancer treatment
Managing the cardiovascular risk of Bruton's Tyrosine Kinase Inhibitors in chronic lymphocytic leukemia
Which foods should you eat together and which separately?- MUST READ for those on Ibrutinib/Imbruvica - concerning advice in pilot study on lower dosing - incl. danger of starting with a lower dose
